F, S., F, S., AS, Y., A, D., A, N., S, H., & K, T. (2026). PBPK Modelling of Antisense Oligonucleotide Therapeutics: Application for Predicting Plasma and Tissue Pharmacokinetics of Bepirovirsen. The AAPS journal, 28(2), . https://doi.org/10.1208/s12248-026-01228-9
Chicago Style (17th ed.) CitationF, Salem, Stader F, Youssef AS, Derbalah A, Nader A, Hood S, and Taskar K. "PBPK Modelling of Antisense Oligonucleotide Therapeutics: Application for Predicting Plasma and Tissue Pharmacokinetics of Bepirovirsen." The AAPS Journal 28, no. 2 (2026). https://doi.org/10.1208/s12248-026-01228-9.
MLA (9th ed.) CitationF, Salem, et al. "PBPK Modelling of Antisense Oligonucleotide Therapeutics: Application for Predicting Plasma and Tissue Pharmacokinetics of Bepirovirsen." The AAPS Journal, vol. 28, no. 2, 2026, https://doi.org/10.1208/s12248-026-01228-9.